|
gptkbp:instance_of
|
gptkb:venture_capital
|
|
gptkbp:focus
|
gptkb:biotechnology
|
|
gptkbp:founded
|
gptkb:2000
|
|
gptkbp:founder
|
gptkb:Noubar_Afeyan
|
|
gptkbp:headquarters
|
gptkb:Cambridge,_Massachusetts
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Flagship Pioneering
|
|
gptkbp:investment
|
gptkb:Zymergen
gptkb:Vaxart
gptkb:Moderna
gptkb:Tessera_Therapeutics
gptkb:Sana_Biotechnology
gptkb:Ginkgo_Bioworks
gptkb:Synthego
gptkb:Cure_Vac
gptkb:TCR2_Therapeutics
Axcella Health
Indigo Agriculture
Seres Therapeutics
Faze Medicines
EQRx
Scribe Therapeutics
Aavanti Bio
|
|
gptkbp:investment_amount
|
$50 million
$1 billion
$100 million
$250 million
$500 million
|
|
gptkbp:investment_strategy
|
Venture capital
Seed funding
Company creation
|
|
gptkbp:notable_products
|
gptkb:Moderna
gptkb:Ginkgo_Bioworks
Axcella Health
Seres Therapeutics
|
|
gptkbp:portfolio_company
|
gptkb:Zymergen
gptkb:Vaxart
gptkb:Tessera_Therapeutics
gptkb:Sana_Biotechnology
gptkb:Synthego
gptkb:Cure_Vac
gptkb:TCR2_Therapeutics
Indigo Agriculture
Faze Medicines
EQRx
Scribe Therapeutics
Aavanti Bio
|
|
gptkbp:website
|
www.flagshippioneering.com
|
|
gptkbp:bfsParent
|
gptkb:Affinivax
gptkb:Tessera_Therapeutics
|
|
gptkbp:bfsLayer
|
5
|